Published in Circ J on August 10, 2010
Electron paramagnetic resonance monitoring of ischemia-induced myocardial oxygen depletion and acidosis in isolated rat hearts using soluble paramagnetic probes. Magn Reson Med (2011) 0.89
Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics. Future Med Chem (2012) 0.86
In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe. Anal Chem (2014) 0.85
Mechanisms Underlying the Emergence of Post-acidosis Arrhythmia at the Tissue Level: A Theoretical Study. Front Physiol (2017) 0.75
Is It Possible to Maintain Consciousness and Spontaneous Ventilation with Chest Compression in the Early Phase of Cardiac Arrest? Case Rep Anesthesiol (2016) 0.75
Evaluation of the impact of atrial fibrillation on rehospitalization events in heart failure patients in recent years. J Cardiol (2012) 2.00
IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation. Circ Res (2004) 1.85
Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2005) 1.52
Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantation. Intern Med (2010) 1.46
Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J (2011) 1.45
Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm. Intern Med (2006) 1.45
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace (2012) 1.45
Effect of hypothermia therapy after outpatient cardiac arrest due to ventricular fibrillation. Circ J (2009) 1.41
Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction. Circ J (2012) 1.40
Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J (2014) 1.39
IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Arterioscler Thromb Vasc Biol (2006) 1.30
Retracted cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ Res (2005) 1.29
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol (2010) 1.07
Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail (2002) 1.07
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis (2009) 0.97
C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels (2003) 0.89
Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovasc Diabetol (2012) 0.86
Inhomogenic effect of bepridil on atrial electrical remodeling in a canine rapid atrial stimulation model. Circ J (2008) 0.85
Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats. Circ J (2011) 0.84
Verapamil suppresses the inhomogeneity of electrical remodeling in a canine long-term rapid atrial stimulation model. Pacing Clin Electrophysiol (2003) 0.83
Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model. Circ J (2003) 0.82
Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res (2004) 0.81
Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome. Curr Vasc Pharmacol (2008) 0.81
Usefulness of a simple prognostication score in prediction of the prognoses of patients with out-of-hospital cardiac arrests. Int Heart J (2013) 0.81
Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB Pathway. Int Heart J (2015) 0.81
Prediction of new onset atrial fibrillation through P wave analysis in 12 lead ECG. Int Heart J (2014) 0.80
Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome. Nutr Metab (Lond) (2011) 0.80
Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med (2006) 0.80
Atrial natriuretic peptide (ANP) suppresses acute atrial electrical remodeling in the canine rapid atrial stimulation model. Int J Cardiol (2007) 0.79
Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model. Int J Cardiol (2010) 0.79
Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent. Catheter Cardiovasc Interv (2013) 0.78
Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J (2005) 0.78
Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation: spectral analysis of surface ECG. Circ J (2006) 0.78
Prediction of clinical recurrence of atrioventricular-nodal reentrant tachycardia (AVNRT) after successful slow pathway ablation. Circ J (2004) 0.78
Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG. Int Heart J (2006) 0.78
Initial experience of mobile cloud ECG system contributing to the shortening of door to balloon time in an acute myocardial infarction patient. Int Heart J (2013) 0.78
Factor Xa in mouse fibroblasts may induce fibrosis more than thrombin. Int Heart J (2014) 0.77
Ezetimibe and reactive oxygen species. Curr Vasc Pharmacol (2011) 0.77
Bepridil block of recombinant human cardiac IKs current shows a time-dependent unblock. J Cardiovasc Pharmacol (2004) 0.77
Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model. Circ J (2006) 0.77
Electrical remodeling of the ventricular myocardium in myocarditis: studies of rat experimental autoimmune myocarditis. Circ J (2002) 0.76
Author's reply: To PMID 22429679. J Cardiol (2013) 0.75
Neutral endopeptidase inhibitor suppresses the early phase of atrial electrical remodeling in a canine rapid atrial pacing model. Indian Pacing Electrophysiol J (2008) 0.75
Neoatherosclerosis 16 years following bare-metal stent implantation: different tissue components in different underlying lesions observed with optical coherence tomography. Int J Cardiol (2013) 0.75
Prolonged recovery time in the left precordial leads reflects increased left ventricular mass in the hypertensive patients. J Electrocardiol (2005) 0.75
Importance of morphological changes in T-U waves during bepridil therapy as a predictor of ventricular arrhythmic event. Circ J (2010) 0.75
The J-wave as a Predictor of Life-Threatening Arrhythmia in ICD Patients. Int Heart J (2017) 0.75
Evaluation of the effect of bepridil on paroxysmal atrial fibrillation: relationship between efficacy and the f-f interval in surface ECG recordings. Circ J (2003) 0.75
Bepridil prevents paroxysmal atrial fibrillation by a class III antiarrhythmic drug effect. Pacing Clin Electrophysiol (2003) 0.75
Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure. Int Heart J (2007) 0.75
Prediction of inappropriate implantable cardioverter-defibrillator therapies through parameters obtained in a simple exercise stress test. Int Heart J (2012) 0.75
Evaluation of exercise-induced T wave changes in patients with idiopathic dilated cardiomyopathy before and after beta-blocker therapy. J Cardiovasc Electrophysiol (2006) 0.75
Risks and benefits of combined use of bucolome and warfarin in anticoagulation therapy. Int Heart J (2010) 0.75
Repetitive evaluation of fibrillation cycle length predicts the efficacy of bepridil for interruption of long-lasting persistent atrial fibrillation. Int Heart J (2011) 0.75
Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia. Circ J (2006) 0.75
Prophylactic statin administration may prevent shortening of the fibrillation cycle length in patients with new-onset atrial fibrillation. Int Heart J (2013) 0.75
Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients. Circ J (2008) 0.75
A young girl with vasospastic angina associated with mutation in endothelial nitric oxide synthase gene--a case report. Angiology (2003) 0.75
Novel Scoring System for Distinction Between Paroxysmal and Non-Paroxysmal Atrial Fibrillation. Circ J (2017) 0.75
Cardioprotective effect of mexiletine in acute myocardial ischemia tudies in the rabbit closed chest ischemia mode. Circ J (2002) 0.75
Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation. Int Heart J (2013) 0.75
Discrimination of Paroxysmal and Persistent Atrial Fibrillation in Patients With New-Onset Atrial Fibrillation. Int Heart J (2016) 0.75
Efficacy and Limitations of Tachycardia Detection Interval Guided Reprogramming for Reduction of Inappropriate Shock in Implantable Cardioverter-Defibrillator Patients. Int Heart J (2016) 0.75